Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)
Clinical trial NCT01387269 · COMPLETED
Trial details
- NCT number
- NCT01387269
- Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-01-01
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.